nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ALB—Vandetanib—thyroid cancer	0.198	0.398	CbGbCtD
Prednisone—CYP2C19—Sorafenib—thyroid cancer	0.0775	0.155	CbGbCtD
Prednisone—ABCB1—Sorafenib—thyroid cancer	0.0625	0.125	CbGbCtD
Prednisone—CYP3A4—Vandetanib—thyroid cancer	0.0622	0.125	CbGbCtD
Prednisone—ABCB1—Doxorubicin—thyroid cancer	0.0379	0.0761	CbGbCtD
Prednisone—CYP3A4—Sorafenib—thyroid cancer	0.0375	0.0751	CbGbCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.0256	0.24	CbGpPWpGaD
Prednisone—CYP3A4—Doxorubicin—thyroid cancer	0.0227	0.0456	CbGbCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.0046	0.043	CbGpPWpGaD
Prednisone—HSD11B1—trachea—thyroid cancer	0.00348	0.21	CbGeAlD
Prednisone—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00311	0.0291	CbGpPWpGaD
Prednisone—SLCO1A2—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00279	0.0261	CbGpPWpGaD
Prednisone—HSD11B1—thyroid gland—thyroid cancer	0.00276	0.166	CbGeAlD
Prednisone—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.00262	0.0245	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00261	0.0244	CbGpPWpGaD
Prednisone—HSD11B1—head—thyroid cancer	0.00244	0.147	CbGeAlD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00244	0.0228	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00244	0.0228	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00207	0.0194	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.00172	0.0161	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.00172	0.0161	CbGpPWpGaD
Prednisone—HSD11B1—lymph node—thyroid cancer	0.00171	0.103	CbGeAlD
Prednisone—HSD11B1—Metabolism—MINPP1—thyroid cancer	0.00168	0.0157	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0015	0.014	CbGpPWpGaD
Prednisone—SLCO1A2—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00146	0.0136	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—NDUFA13—thyroid cancer	0.00143	0.0134	CbGpPWpGaD
Prednisone—ALB—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00136	0.0127	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00136	0.0127	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CHST14—thyroid cancer	0.00135	0.0126	CbGpPWpGaD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.00119	0.0111	CbGpPWpGaD
Prednisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.00114	0.0106	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.00111	0.0104	CbGpPWpGaD
Prednisone—NR3C1—neck—thyroid cancer	0.0011	0.0659	CbGeAlD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00109	0.0102	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—HPGD—thyroid cancer	0.00108	0.0101	CbGpPWpGaD
Prednisone—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00107	0.01	CbGpPWpGaD
Prednisone—Petechiae—Epirubicin—thyroid cancer	0.000933	0.00247	CcSEcCtD
Prednisone—Arrhythmia—Sorafenib—thyroid cancer	0.000931	0.00247	CcSEcCtD
Prednisone—Alopecia—Sorafenib—thyroid cancer	0.000921	0.00244	CcSEcCtD
Prednisone—Fungal infection—Doxorubicin—thyroid cancer	0.00092	0.00243	CcSEcCtD
Prednisone—Mental disorder—Sorafenib—thyroid cancer	0.000914	0.00242	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00091	0.00851	CbGpPWpGaD
Prednisone—Erythema—Sorafenib—thyroid cancer	0.000908	0.0024	CcSEcCtD
Prednisone—Malnutrition—Sorafenib—thyroid cancer	0.000908	0.0024	CcSEcCtD
Prednisone—Necrosis—Doxorubicin—thyroid cancer	0.000905	0.00239	CcSEcCtD
Prednisone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000898	0.00238	CcSEcCtD
Prednisone—Abscess—Doxorubicin—thyroid cancer	0.000897	0.00238	CcSEcCtD
Prednisone—Delirium—Epirubicin—thyroid cancer	0.000892	0.00236	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00088	0.00823	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000879	0.00822	CbGpPWpGaD
Prednisone—Glycosuria—Doxorubicin—thyroid cancer	0.000876	0.00232	CcSEcCtD
Prednisone—Amenorrhoea—Epirubicin—thyroid cancer	0.000873	0.00231	CcSEcCtD
Prednisone—Body temperature increased—Vandetanib—thyroid cancer	0.000868	0.0023	CcSEcCtD
Prednisone—Abdominal pain—Vandetanib—thyroid cancer	0.000868	0.0023	CcSEcCtD
Prednisone—Petechiae—Doxorubicin—thyroid cancer	0.000863	0.00228	CcSEcCtD
Prednisone—NR3C1—saliva-secreting gland—thyroid cancer	0.000855	0.0514	CbGeAlD
Prednisone—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000853	0.00797	CbGpPWpGaD
Prednisone—Viral infection—Epirubicin—thyroid cancer	0.00085	0.00225	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000846	0.00791	CbGpPWpGaD
Prednisone—Arthropathy—Epirubicin—thyroid cancer	0.000844	0.00223	CcSEcCtD
Prednisone—Anaemia—Sorafenib—thyroid cancer	0.000839	0.00222	CcSEcCtD
Prednisone—Angioedema—Sorafenib—thyroid cancer	0.000829	0.0022	CcSEcCtD
Prednisone—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.000828	0.00774	CbGpPWpGaD
Prednisone—Delirium—Doxorubicin—thyroid cancer	0.000826	0.00218	CcSEcCtD
Prednisone—Syncope—Sorafenib—thyroid cancer	0.000814	0.00215	CcSEcCtD
Prednisone—Ulcer—Epirubicin—thyroid cancer	0.000811	0.00215	CcSEcCtD
Prednisone—Amenorrhoea—Doxorubicin—thyroid cancer	0.000808	0.00214	CcSEcCtD
Prednisone—Loss of consciousness—Sorafenib—thyroid cancer	0.000798	0.00211	CcSEcCtD
Prednisone—Asthenia—Vandetanib—thyroid cancer	0.000788	0.00209	CcSEcCtD
Prednisone—Viral infection—Doxorubicin—thyroid cancer	0.000786	0.00208	CcSEcCtD
Prednisone—Hypertension—Sorafenib—thyroid cancer	0.000784	0.00207	CcSEcCtD
Prednisone—Arthropathy—Doxorubicin—thyroid cancer	0.000781	0.00207	CcSEcCtD
Prednisone—Pruritus—Vandetanib—thyroid cancer	0.000777	0.00206	CcSEcCtD
Prednisone—Myalgia—Sorafenib—thyroid cancer	0.000773	0.00205	CcSEcCtD
Prednisone—Arthralgia—Sorafenib—thyroid cancer	0.000773	0.00205	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000767	0.00203	CcSEcCtD
Prednisone—Hiccups—Epirubicin—thyroid cancer	0.000767	0.00203	CcSEcCtD
Prednisone—Diarrhoea—Vandetanib—thyroid cancer	0.000751	0.00199	CcSEcCtD
Prednisone—Ulcer—Doxorubicin—thyroid cancer	0.000751	0.00199	CcSEcCtD
Prednisone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000741	0.00196	CcSEcCtD
Prednisone—SLCO1A2—head—thyroid cancer	0.000739	0.0445	CbGeAlD
Prednisone—Infection—Sorafenib—thyroid cancer	0.000736	0.00195	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.000735	0.00688	CbGpPWpGaD
Prednisone—Skin exfoliation—Epirubicin—thyroid cancer	0.000733	0.00194	CcSEcCtD
Prednisone—Shock—Sorafenib—thyroid cancer	0.000729	0.00193	CcSEcCtD
Prednisone—Fluid retention—Epirubicin—thyroid cancer	0.000729	0.00193	CcSEcCtD
Prednisone—Nervous system disorder—Sorafenib—thyroid cancer	0.000726	0.00192	CcSEcCtD
Prednisone—Dizziness—Vandetanib—thyroid cancer	0.000726	0.00192	CcSEcCtD
Prednisone—Neuropathy—Epirubicin—thyroid cancer	0.00072	0.00191	CcSEcCtD
Prednisone—Skin disorder—Sorafenib—thyroid cancer	0.00072	0.0019	CcSEcCtD
Prednisone—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000712	0.00666	CbGpPWpGaD
Prednisone—Hiccups—Doxorubicin—thyroid cancer	0.00071	0.00188	CcSEcCtD
Prednisone—Anorexia—Sorafenib—thyroid cancer	0.000706	0.00187	CcSEcCtD
Prednisone—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000703	0.00657	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.000702	0.00657	CbGpPWpGaD
Prednisone—Oesophagitis—Epirubicin—thyroid cancer	0.000701	0.00186	CcSEcCtD
Prednisone—Vomiting—Vandetanib—thyroid cancer	0.000698	0.00185	CcSEcCtD
Prednisone—Ecchymosis—Epirubicin—thyroid cancer	0.000694	0.00184	CcSEcCtD
Prednisone—Rash—Vandetanib—thyroid cancer	0.000692	0.00183	CcSEcCtD
Prednisone—Dermatitis—Vandetanib—thyroid cancer	0.000692	0.00183	CcSEcCtD
Prednisone—Headache—Vandetanib—thyroid cancer	0.000688	0.00182	CcSEcCtD
Prednisone—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000686	0.00641	CbGpPWpGaD
Prednisone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000683	0.00181	CcSEcCtD
Prednisone—Skin exfoliation—Doxorubicin—thyroid cancer	0.000678	0.00179	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000675	0.00179	CcSEcCtD
Prednisone—Fluid retention—Doxorubicin—thyroid cancer	0.000674	0.00178	CcSEcCtD
Prednisone—Neuropathy—Doxorubicin—thyroid cancer	0.000667	0.00176	CcSEcCtD
Prednisone—Sepsis—Epirubicin—thyroid cancer	0.000666	0.00176	CcSEcCtD
Prednisone—NR3C1—trachea—thyroid cancer	0.000659	0.0397	CbGeAlD
Prednisone—Nausea—Vandetanib—thyroid cancer	0.000652	0.00173	CcSEcCtD
Prednisone—Dyspepsia—Sorafenib—thyroid cancer	0.000652	0.00173	CcSEcCtD
Prednisone—Oesophagitis—Doxorubicin—thyroid cancer	0.000649	0.00172	CcSEcCtD
Prednisone—Decreased appetite—Sorafenib—thyroid cancer	0.000644	0.0017	CcSEcCtD
Prednisone—Thrombophlebitis—Epirubicin—thyroid cancer	0.000643	0.0017	CcSEcCtD
Prednisone—Ecchymosis—Doxorubicin—thyroid cancer	0.000642	0.0017	CcSEcCtD
Prednisone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000641	0.006	CbGpPWpGaD
Prednisone—Diabetes mellitus—Epirubicin—thyroid cancer	0.00064	0.0017	CcSEcCtD
Prednisone—Fatigue—Sorafenib—thyroid cancer	0.000639	0.00169	CcSEcCtD
Prednisone—Constipation—Sorafenib—thyroid cancer	0.000633	0.00168	CcSEcCtD
Prednisone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000632	0.00167	CcSEcCtD
Prednisone—HSD11B1—Metabolism—TPR—thyroid cancer	0.000623	0.00583	CbGpPWpGaD
Prednisone—Vascular purpura—Epirubicin—thyroid cancer	0.000623	0.00165	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00062	0.0058	CbGpPWpGaD
Prednisone—Sepsis—Doxorubicin—thyroid cancer	0.000616	0.00163	CcSEcCtD
Prednisone—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.000615	0.00575	CbGpPWpGaD
Prednisone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000614	0.00163	CcSEcCtD
Prednisone—HSD11B1—Metabolism—PRKAR1A—thyroid cancer	0.000613	0.00573	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000611	0.00571	CbGpPWpGaD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000608	0.00569	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000606	0.0016	CcSEcCtD
Prednisone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000595	0.00158	CcSEcCtD
Prednisone—Increased appetite—Epirubicin—thyroid cancer	0.000593	0.00157	CcSEcCtD
Prednisone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000593	0.00157	CcSEcCtD
Prednisone—Urticaria—Sorafenib—thyroid cancer	0.000589	0.00156	CcSEcCtD
Prednisone—Abdominal pain—Sorafenib—thyroid cancer	0.000586	0.00155	CcSEcCtD
Prednisone—Body temperature increased—Sorafenib—thyroid cancer	0.000586	0.00155	CcSEcCtD
Prednisone—Purpura—Epirubicin—thyroid cancer	0.000578	0.00153	CcSEcCtD
Prednisone—Vascular purpura—Doxorubicin—thyroid cancer	0.000576	0.00152	CcSEcCtD
Prednisone—Cardiac failure—Epirubicin—thyroid cancer	0.000571	0.00151	CcSEcCtD
Prednisone—Lethargy—Epirubicin—thyroid cancer	0.000568	0.0015	CcSEcCtD
Prednisone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000568	0.0015	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000562	0.00526	CbGpPWpGaD
Prednisone—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000557	0.00147	CcSEcCtD
Prednisone—Osteoarthritis—Epirubicin—thyroid cancer	0.000557	0.00147	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000555	0.0052	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000555	0.00519	CbGpPWpGaD
Prednisone—Increased appetite—Doxorubicin—thyroid cancer	0.000549	0.00145	CcSEcCtD
Prednisone—Affect lability—Epirubicin—thyroid cancer	0.000548	0.00145	CcSEcCtD
Prednisone—Hypersensitivity—Sorafenib—thyroid cancer	0.000546	0.00144	CcSEcCtD
Prednisone—Face oedema—Epirubicin—thyroid cancer	0.000538	0.00142	CcSEcCtD
Prednisone—Purpura—Doxorubicin—thyroid cancer	0.000535	0.00142	CcSEcCtD
Prednisone—Asthenia—Sorafenib—thyroid cancer	0.000532	0.00141	CcSEcCtD
Prednisone—Cardiac arrest—Epirubicin—thyroid cancer	0.00053	0.0014	CcSEcCtD
Prednisone—Cardiac failure—Doxorubicin—thyroid cancer	0.000528	0.0014	CcSEcCtD
Prednisone—Mood swings—Epirubicin—thyroid cancer	0.000528	0.0014	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—thyroid cancer	0.000526	0.00139	CcSEcCtD
Prednisone—Pruritus—Sorafenib—thyroid cancer	0.000524	0.00139	CcSEcCtD
Prednisone—NR3C1—thyroid gland—thyroid cancer	0.000522	0.0314	CbGeAlD
Prednisone—Osteoarthritis—Doxorubicin—thyroid cancer	0.000515	0.00136	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000515	0.00136	CcSEcCtD
Prednisone—ALB—lymph node—thyroid cancer	0.000515	0.031	CbGeAlD
Prednisone—Dry skin—Epirubicin—thyroid cancer	0.000511	0.00135	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—thyroid cancer	0.000507	0.00134	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—thyroid cancer	0.000507	0.00134	CcSEcCtD
Prednisone—Diarrhoea—Sorafenib—thyroid cancer	0.000507	0.00134	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000507	0.00474	CbGpPWpGaD
Prednisone—Face oedema—Doxorubicin—thyroid cancer	0.000498	0.00132	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000494	0.00462	CbGpPWpGaD
Prednisone—Muscular weakness—Epirubicin—thyroid cancer	0.000491	0.0013	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000491	0.0013	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—thyroid cancer	0.00049	0.0013	CcSEcCtD
Prednisone—Dizziness—Sorafenib—thyroid cancer	0.00049	0.0013	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—thyroid cancer	0.000488	0.00129	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—thyroid cancer	0.000485	0.00128	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000479	0.00448	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000477	0.00446	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000477	0.00446	CbGpPWpGaD
Prednisone—Dry skin—Doxorubicin—thyroid cancer	0.000472	0.00125	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—thyroid cancer	0.000472	0.00125	CcSEcCtD
Prednisone—Vomiting—Sorafenib—thyroid cancer	0.000471	0.00125	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000469	0.00124	CcSEcCtD
Prednisone—Rash—Sorafenib—thyroid cancer	0.000467	0.00124	CcSEcCtD
Prednisone—Dermatitis—Sorafenib—thyroid cancer	0.000467	0.00124	CcSEcCtD
Prednisone—HSD11B1—Metabolism—SLC5A5—thyroid cancer	0.000466	0.00436	CbGpPWpGaD
Prednisone—Headache—Sorafenib—thyroid cancer	0.000464	0.00123	CcSEcCtD
Prednisone—NR3C1—head—thyroid cancer	0.000463	0.0278	CbGeAlD
Prednisone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000455	0.0012	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—thyroid cancer	0.000455	0.0012	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—thyroid cancer	0.00045	0.00119	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—thyroid cancer	0.000448	0.00119	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000444	0.00416	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000443	0.00415	CbGpPWpGaD
Prednisone—Nausea—Sorafenib—thyroid cancer	0.00044	0.00116	CcSEcCtD
Prednisone—Weight increased—Epirubicin—thyroid cancer	0.000438	0.00116	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000437	0.00409	CbGpPWpGaD
Prednisone—Pancreatitis—Doxorubicin—thyroid cancer	0.000437	0.00116	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—thyroid cancer	0.000436	0.00115	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000434	0.00115	CcSEcCtD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000425	0.00397	CbGpPWpGaD
Prednisone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000422	0.00395	CbGpPWpGaD
Prednisone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000421	0.00111	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—thyroid cancer	0.000417	0.0011	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000416	0.00389	CbGpPWpGaD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000412	0.00386	CbGpPWpGaD
Prednisone—Weight increased—Doxorubicin—thyroid cancer	0.000405	0.00107	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—thyroid cancer	0.000403	0.00107	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000402	0.00106	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—thyroid cancer	0.000392	0.00104	CcSEcCtD
Prednisone—HSD11B1—Metabolism—RXRA—thyroid cancer	0.000392	0.00366	CbGpPWpGaD
Prednisone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000389	0.00103	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—thyroid cancer	0.000387	0.00103	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—thyroid cancer	0.000385	0.00102	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000381	0.00356	CbGpPWpGaD
Prednisone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000379	0.001	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000373	0.00349	CbGpPWpGaD
Prednisone—Bradycardia—Doxorubicin—thyroid cancer	0.000363	0.000961	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—thyroid cancer	0.00036	0.000953	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—thyroid cancer	0.000358	0.000949	CcSEcCtD
Prednisone—Flushing—Epirubicin—thyroid cancer	0.000358	0.000947	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.000357	0.00334	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000357	0.00334	CbGpPWpGaD
Prednisone—Haemorrhage—Doxorubicin—thyroid cancer	0.000357	0.000944	CcSEcCtD
Prednisone—ABCB1—trachea—thyroid cancer	0.000353	0.0212	CbGeAlD
Prednisone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00035	0.000927	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—thyroid cancer	0.00035	0.000925	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—thyroid cancer	0.000348	0.000921	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000344	0.00322	CbGpPWpGaD
Prednisone—Arrhythmia—Epirubicin—thyroid cancer	0.000344	0.000911	CcSEcCtD
Prednisone—Alopecia—Epirubicin—thyroid cancer	0.000341	0.000901	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—thyroid cancer	0.000338	0.000894	CcSEcCtD
Prednisone—Erythema—Epirubicin—thyroid cancer	0.000335	0.000888	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—thyroid cancer	0.000335	0.000888	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—thyroid cancer	0.000333	0.000882	CcSEcCtD
Prednisone—Flushing—Doxorubicin—thyroid cancer	0.000331	0.000876	CcSEcCtD
Prednisone—NR3C1—lymph node—thyroid cancer	0.000324	0.0195	CbGeAlD
Prednisone—Angiopathy—Doxorubicin—thyroid cancer	0.000323	0.000856	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—thyroid cancer	0.000322	0.000852	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—thyroid cancer	0.000319	0.000843	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—thyroid cancer	0.000316	0.000837	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—thyroid cancer	0.000315	0.000834	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—thyroid cancer	0.000312	0.000827	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000311	0.000824	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—thyroid cancer	0.00031	0.000822	CcSEcCtD
Prednisone—Erythema—Doxorubicin—thyroid cancer	0.00031	0.000822	CcSEcCtD
Prednisone—Anaemia—Epirubicin—thyroid cancer	0.00031	0.000821	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000309	0.00289	CbGpPWpGaD
Prednisone—Agitation—Epirubicin—thyroid cancer	0.000308	0.000816	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.000306	0.00287	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000306	0.00286	CbGpPWpGaD
Prednisone—Malaise—Epirubicin—thyroid cancer	0.000303	0.000801	CcSEcCtD
Prednisone—Vertigo—Epirubicin—thyroid cancer	0.000301	0.000798	CcSEcCtD
Prednisone—Syncope—Epirubicin—thyroid cancer	0.000301	0.000796	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000298	0.00279	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000296	0.00276	CbGpPWpGaD
Prednisone—Loss of consciousness—Epirubicin—thyroid cancer	0.000295	0.00078	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—thyroid cancer	0.000293	0.000774	CcSEcCtD
Prednisone—Convulsion—Epirubicin—thyroid cancer	0.000291	0.000769	CcSEcCtD
Prednisone—Hypertension—Epirubicin—thyroid cancer	0.00029	0.000767	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000288	0.000762	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—thyroid cancer	0.000287	0.000759	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—thyroid cancer	0.000286	0.000756	CcSEcCtD
Prednisone—Myalgia—Epirubicin—thyroid cancer	0.000286	0.000756	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000285	0.00267	CbGpPWpGaD
Prednisone—Agitation—Doxorubicin—thyroid cancer	0.000285	0.000755	CcSEcCtD
Prednisone—Anxiety—Epirubicin—thyroid cancer	0.000285	0.000753	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000284	0.000751	CcSEcCtD
Prednisone—Discomfort—Epirubicin—thyroid cancer	0.000282	0.000747	CcSEcCtD
Prednisone—Malaise—Doxorubicin—thyroid cancer	0.00028	0.000741	CcSEcCtD
Prednisone—ABCB1—thyroid gland—thyroid cancer	0.000279	0.0168	CbGeAlD
Prednisone—Vertigo—Doxorubicin—thyroid cancer	0.000279	0.000738	CcSEcCtD
Prednisone—Syncope—Doxorubicin—thyroid cancer	0.000278	0.000737	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000274	0.000725	CcSEcCtD
Prednisone—Oedema—Epirubicin—thyroid cancer	0.000274	0.000725	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000273	0.000722	CcSEcCtD
Prednisone—Infection—Epirubicin—thyroid cancer	0.000272	0.00072	CcSEcCtD
Prednisone—Shock—Epirubicin—thyroid cancer	0.000269	0.000713	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—thyroid cancer	0.000269	0.000712	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—thyroid cancer	0.000268	0.000711	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—thyroid cancer	0.000268	0.000709	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—thyroid cancer	0.000267	0.000707	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000267	0.0025	CbGpPWpGaD
Prednisone—Skin disorder—Epirubicin—thyroid cancer	0.000266	0.000704	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000265	0.000701	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—thyroid cancer	0.000264	0.000699	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—thyroid cancer	0.000264	0.000699	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—thyroid cancer	0.000263	0.000697	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000263	0.00246	CbGpPWpGaD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000262	0.000695	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—thyroid cancer	0.000261	0.000691	CcSEcCtD
Prednisone—Anorexia—Epirubicin—thyroid cancer	0.000261	0.000691	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000261	0.00244	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000256	0.00239	CbGpPWpGaD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000254	0.00238	CbGpPWpGaD
Prednisone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000253	0.00067	CcSEcCtD
Prednisone—Oedema—Doxorubicin—thyroid cancer	0.000253	0.00067	CcSEcCtD
Prednisone—Infection—Doxorubicin—thyroid cancer	0.000252	0.000666	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000249	0.00066	CcSEcCtD
Prednisone—Shock—Doxorubicin—thyroid cancer	0.000249	0.00066	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000248	0.000658	CcSEcCtD
Prednisone—ABCB1—head—thyroid cancer	0.000248	0.0149	CbGeAlD
Prednisone—Insomnia—Epirubicin—thyroid cancer	0.000248	0.000655	CcSEcCtD
Prednisone—HSD11B1—Metabolism—PPARG—thyroid cancer	0.000247	0.00231	CbGpPWpGaD
Prednisone—Tachycardia—Doxorubicin—thyroid cancer	0.000247	0.000654	CcSEcCtD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000247	0.00231	CbGpPWpGaD
Prednisone—Skin disorder—Doxorubicin—thyroid cancer	0.000246	0.000651	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—thyroid cancer	0.000246	0.000651	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.000245	0.00229	CbGpPWpGaD
Prednisone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000245	0.000648	CcSEcCtD
Prednisone—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000244	0.00228	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000242	0.00227	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000242	0.00227	CbGpPWpGaD
Prednisone—Anorexia—Doxorubicin—thyroid cancer	0.000241	0.000639	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—thyroid cancer	0.000241	0.000638	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000238	0.00223	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000238	0.00223	CbGpPWpGaD
Prednisone—Decreased appetite—Epirubicin—thyroid cancer	0.000238	0.00063	CcSEcCtD
Prednisone—Fatigue—Epirubicin—thyroid cancer	0.000236	0.000625	CcSEcCtD
Prednisone—Constipation—Epirubicin—thyroid cancer	0.000234	0.00062	CcSEcCtD
Prednisone—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000233	0.00218	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000233	0.00218	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000231	0.000611	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—thyroid cancer	0.000229	0.000606	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—thyroid cancer	0.000227	0.000602	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000227	0.00212	CbGpPWpGaD
Prednisone—Feeling abnormal—Epirubicin—thyroid cancer	0.000226	0.000597	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000224	0.000593	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—thyroid cancer	0.000223	0.00059	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—thyroid cancer	0.00022	0.000583	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—thyroid cancer	0.000218	0.000578	CcSEcCtD
Prednisone—Urticaria—Epirubicin—thyroid cancer	0.000217	0.000576	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000217	0.00203	CbGpPWpGaD
Prednisone—Constipation—Doxorubicin—thyroid cancer	0.000217	0.000573	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—thyroid cancer	0.000216	0.000573	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—thyroid cancer	0.000216	0.000573	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000209	0.000553	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000207	0.000548	CcSEcCtD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000207	0.00194	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000202	0.00189	CbGpPWpGaD
Prednisone—Hypersensitivity—Epirubicin—thyroid cancer	0.000202	0.000534	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—thyroid cancer	0.000201	0.000533	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—thyroid cancer	0.0002	0.00053	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—thyroid cancer	0.0002	0.00053	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—HPGD—thyroid cancer	0.000197	0.00185	CbGpPWpGaD
Prednisone—Asthenia—Epirubicin—thyroid cancer	0.000196	0.00052	CcSEcCtD
Prednisone—HSD11B1—Metabolism—PTGS2—thyroid cancer	0.000195	0.00182	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000195	0.00182	CbGpPWpGaD
Prednisone—Pruritus—Epirubicin—thyroid cancer	0.000194	0.000513	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—thyroid cancer	0.000187	0.000496	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000187	0.000494	CcSEcCtD
Prednisone—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000183	0.00171	CbGpPWpGaD
Prednisone—Asthenia—Doxorubicin—thyroid cancer	0.000182	0.000481	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000181	0.0017	CbGpPWpGaD
Prednisone—Dizziness—Epirubicin—thyroid cancer	0.000181	0.000479	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—thyroid cancer	0.000179	0.000474	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000178	0.00166	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000174	0.00163	CbGpPWpGaD
Prednisone—Vomiting—Epirubicin—thyroid cancer	0.000174	0.000461	CcSEcCtD
Prednisone—ABCB1—lymph node—thyroid cancer	0.000173	0.0104	CbGeAlD
Prednisone—Diarrhoea—Doxorubicin—thyroid cancer	0.000173	0.000459	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000173	0.00162	CbGpPWpGaD
Prednisone—Rash—Epirubicin—thyroid cancer	0.000173	0.000457	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—thyroid cancer	0.000172	0.000456	CcSEcCtD
Prednisone—NR3C1—Gene Expression—THRB—thyroid cancer	0.000172	0.00161	CbGpPWpGaD
Prednisone—Headache—Epirubicin—thyroid cancer	0.000172	0.000454	CcSEcCtD
Prednisone—HSD11B1—Metabolism—PTEN—thyroid cancer	0.00017	0.00159	CbGpPWpGaD
Prednisone—Dizziness—Doxorubicin—thyroid cancer	0.000168	0.000443	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000164	0.00154	CbGpPWpGaD
Prednisone—Nausea—Epirubicin—thyroid cancer	0.000163	0.00043	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—thyroid cancer	0.000161	0.000426	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00016	0.0015	CbGpPWpGaD
Prednisone—Rash—Doxorubicin—thyroid cancer	0.00016	0.000423	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—thyroid cancer	0.00016	0.000422	CcSEcCtD
Prednisone—Headache—Doxorubicin—thyroid cancer	0.000159	0.00042	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000152	0.00142	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000152	0.00142	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000152	0.00142	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000151	0.00142	CbGpPWpGaD
Prednisone—Nausea—Doxorubicin—thyroid cancer	0.00015	0.000398	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.00015	0.0014	CbGpPWpGaD
Prednisone—ALB—Metabolism—MINPP1—thyroid cancer	0.00015	0.0014	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PRKAR1A—thyroid cancer	0.000134	0.00126	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000134	0.00126	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000131	0.00123	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—thyroid cancer	0.00013	0.00121	CbGpPWpGaD
Prednisone—ALB—Metabolism—NDUFA13—thyroid cancer	0.000127	0.00119	CbGpPWpGaD
Prednisone—ALB—Metabolism—CHST14—thyroid cancer	0.00012	0.00112	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000118	0.00111	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	0.000118	0.00111	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000116	0.00109	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—TPR—thyroid cancer	0.000116	0.00109	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.000114	0.00107	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TPR—thyroid cancer	0.000113	0.00106	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	0.000112	0.00104	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000112	0.00104	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.00011	0.00103	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000109	0.00102	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000107	0.00101	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CHST14—thyroid cancer	0.000105	0.000981	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000104	0.00097	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000104	0.00097	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000102	0.000954	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000101	0.000946	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—thyroid cancer	9.78e-05	0.000915	CbGpPWpGaD
Prednisone—ALB—Metabolism—HPGD—thyroid cancer	9.65e-05	0.000903	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	9.59e-05	0.000897	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	9.59e-05	0.000897	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA2—thyroid cancer	8.91e-05	0.000833	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.86e-05	0.000829	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HPGD—thyroid cancer	8.66e-05	0.00081	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	8.49e-05	0.000794	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HPGD—thyroid cancer	8.45e-05	0.000791	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	8.16e-05	0.000763	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MINPP1—thyroid cancer	8.08e-05	0.000756	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.96e-05	0.000744	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.83e-05	0.000732	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.76e-05	0.000726	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.44e-05	0.000696	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	7.37e-05	0.000689	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—RXRA—thyroid cancer	7.31e-05	0.000684	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—RXRA—thyroid cancer	7.13e-05	0.000667	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.11e-05	0.000665	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.03e-05	0.000657	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.94e-05	0.000649	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	6.87e-05	0.000643	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.52e-05	0.00061	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CHST14—thyroid cancer	6.46e-05	0.000604	CbGpPWpGaD
Prednisone—ALB—Metabolism—TPR—thyroid cancer	5.54e-05	0.000518	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.46e-05	0.000511	CbGpPWpGaD
Prednisone—ALB—Metabolism—PRKAR1A—thyroid cancer	5.45e-05	0.00051	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HPGD—thyroid cancer	5.21e-05	0.000487	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TPR—thyroid cancer	4.98e-05	0.000465	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.94e-05	0.000462	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	4.89e-05	0.000458	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TPR—thyroid cancer	4.86e-05	0.000454	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.85e-05	0.000454	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	4.78e-05	0.000447	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARG—thyroid cancer	4.62e-05	0.000432	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARG—thyroid cancer	4.5e-05	0.000421	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.44e-05	0.000415	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	4.16e-05	0.000389	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A5—thyroid cancer	4.15e-05	0.000388	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.1e-05	0.000383	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.89e-05	0.000364	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	3.72e-05	0.000348	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A5—thyroid cancer	3.64e-05	0.00034	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—thyroid cancer	3.54e-05	0.000331	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.49e-05	0.000326	CbGpPWpGaD
Prednisone—ALB—Metabolism—RXRA—thyroid cancer	3.49e-05	0.000326	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.39e-05	0.000317	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—thyroid cancer	3.32e-05	0.000311	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—RXRA—thyroid cancer	3.13e-05	0.000293	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—thyroid cancer	3.09e-05	0.000289	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—RXRA—thyroid cancer	3.05e-05	0.000286	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.04e-05	0.000285	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TPR—thyroid cancer	2.99e-05	0.00028	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.94e-05	0.000275	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—thyroid cancer	2.86e-05	0.000267	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—thyroid cancer	2.54e-05	0.000238	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—thyroid cancer	2.43e-05	0.000227	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.24e-05	0.000209	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARG—thyroid cancer	2.2e-05	0.000206	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—thyroid cancer	2.15e-05	0.000201	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARG—thyroid cancer	1.98e-05	0.000185	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARG—thyroid cancer	1.93e-05	0.00018	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.88e-05	0.000176	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—thyroid cancer	1.83e-05	0.000171	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—thyroid cancer	1.78e-05	0.000167	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—thyroid cancer	1.73e-05	0.000162	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.55e-05	0.000145	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—thyroid cancer	1.52e-05	0.000142	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—thyroid cancer	1.51e-05	0.000141	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—thyroid cancer	1.36e-05	0.000127	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—thyroid cancer	1.32e-05	0.000124	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARG—thyroid cancer	1.19e-05	0.000111	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—thyroid cancer	9.35e-06	8.74e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—thyroid cancer	8.7e-06	8.14e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—thyroid cancer	8.15e-06	7.62e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—thyroid cancer	7.81e-06	7.31e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—thyroid cancer	7.62e-06	7.13e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—thyroid cancer	4.7e-06	4.39e-05	CbGpPWpGaD
